Capital Fund Management (CFM)’s Idexx Laboratories IDXX Stock Holding History

Capital Fund Management (CFM)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,300	Closed	-$6.69M	–	2200
2023 Q3	$6.69M	Buy	+15,300	New	+$7.63M	0.02%	794
2020 Q1	–	Sell	-800	Closed	-$209K	–	1779
2019 Q4	$209K	Sell	800 -2,200	-73%	-$580K	﹤0.01%	1743
2019 Q3	$816K	Sell	3,000 -5,100	-63%	-$1.42M	0.01%	1073
2019 Q2	$2.23M	Buy	8,100 +6,800	+523%	+$1.68M	0.02%	773
2019 Q1	$291K	Sell	1,300 -5,500	-81%	-$1.14M	﹤0.01%	1452
2018 Q4	$1.26M	Sell	6,800 -19,100	-74%	-$3.92M	0.01%	1023
2018 Q3	$6.47M	Sell	25,900 -600	-2%	-$146K	0.04%	663
2018 Q2	$5.78M	Buy	26,500 +17,300	+188%	+$3.56M	0.03%	681
2018 Q1	$1.76M	Sell	9,200 -5,600	-38%	-$1.03M	0.01%	1051
2017 Q4	$2.31M	Buy	14,800 +9,600	+185%	+$1.51M	0.01%	938
2017 Q3	$809K	Buy	+5,200	New	+$822K	0.01%	1040
2017 Q2	–	Sell	-1,800	Closed	-$278K	–	1578
2017 Q1	$278K	Buy	+1,800	New	+$248K	﹤0.01%	1314
2013 Q3	–	Sell	-26,400	Closed	-$1.19M	–	1713
2013 Q2	$1.19M	Buy	+26,400	New	+$1.15M	0.02%	755

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s IDXX Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Idexx Laboratories (IDXX) stake by 5.2% in Q1 2026, selling an estimated $1.5M and leaving 42,889 shares worth $24.1M. The position accounts for 0.11% of the portfolio, ranked #253.

Capital Fund Management (CFM) first reported a position in IDXX in Q3 2014 and has held it in 25 quarters since. The position peaked at $30.6M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Capital Fund Management (CFM) held 42,889 shares of Idexx Laboratories worth $24.1M as of Q1 2026.
Capital Fund Management (CFM) sold 2,332 Idexx Laboratories shares in Q1 2026, an estimated $1.5M.
Idexx Laboratories made up 0.11% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #253 holding.
Capital Fund Management (CFM) first reported a position in Idexx Laboratories in Q3 2014 and has held it in 25 quarters since.
Capital Fund Management (CFM)'s Idexx Laboratories position peaked at $30.6M in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.